PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for First Quarter Fiscal Year 2017 on Wednesday, October 26, 2016 after the close of the stock market.
PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, October 27, 2016, to discuss the results. To access the webcast, visit the Investor Section of PAREXEL’s website at www.investor.parexel.com. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL’s First Quarter Fiscal Year 2017 earnings call.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, and technology solutions and services to the worldwide pharmaceutical, biotechnology, medical device, and diagnostics industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 84 locations in 51 countries around the world, and had approximately 18,600 employees in the fourth quarter. For more information about PAREXEL International visit www.PAREXEL.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161013005816/en/Business Wire
Last updated on: 13/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.